Montis Biosciences
Montis Biosciences • Beyond complement
Leuven, Belgium · $9.1M raised
- Headquarters
- Leuven
- Business Model
- B2B
- Website
- montisbio.com
- Total Funding
- $9.1M
- Last Round
- $9.1M SeedFeb 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Montis Biosciences develops cutting-edge C1q-targeting antibody therapies for neuroinflammatory diseases and cancer.
Summary
Montis Biosciences is a Biotech company based in Leuven, Belgium. It has raised $9.1M in total across 1 round, most recently a $9.1M Seed round in Feb 2025. Investors include Polaris Partners, 3E Bioventures Capital and Takeda (JP).
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/montis-biosciences"><img src="https://indexed.vc/api/badge/company/montis-biosciences" alt="Montis Biosciences on Indexed.vc" width="260" height="76" /></a>